AEON Biopharma Announces Topline Results from Phase 2 Trial
– ABP-450 doses of 150 units and 195 units showed treatment effect of 4.8 days and 5.0 days, respectively, in the mean change from baseline in monthly...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Rates Statistically. Real-time updates on events, politics, business and more.